Related Experiment Video
Updated: Jun 16, 2026
08:23
CIRCLE-Seq for Interrogation of Off-Target Gene Editing
Published on: November 1, 2024
Cell Therapy Using Induced Pluripotent Stem (iPS) Cells Meets Next-Next Generation DNA Sequencing Technology
1Department of Human Genome Research, Kazusa DNA Research Institute, 2-6-7 Kazusa-Kamatari, Kisarazu, Chiba 292-0818, Japan.
Current Genomics
|February 2, 2010
Summary
Induced pluripotent stem (iPS) cell technology advances cell and gene therapies. Whole-genome sequencing of iPS cells is crucial for patient safety and effective disease treatment.
Area of Science:
- Biotechnology
- Genomics
- Regenerative Medicine
Background:
- Induced pluripotent stem (iPS) cell technology represents a significant advancement in regenerative medicine.
- The convergence of technological improvements across research fields is paving the way for novel disease treatment approaches.
Purpose of the Study:
- To highlight the critical role of next-generation DNA sequencing and bioinformatics in the successful clinical application of iPS cell therapy.
- To emphasize the necessity of whole-genome sequencing for patient-derived iPS cell colonies before therapeutic use.
Main Methods:
- Leveraging advancements in iPS cell technology.
- Utilizing next-generation DNA sequencing for comprehensive genomic analysis.
- Applying bioinformatics for the analysis of recipient genomes.
Main Results:
- iPS cell technology is progressing towards clinical reality.
- Whole-genome sequencing of iPS cell colonies can mitigate risks from spontaneous mutations.
- Integration of sequencing and bioinformatics is essential for safe iPS cell therapy.
Conclusions:
- The successful clinical application of iPS cell therapy hinges on integrating advanced DNA sequencing and bioinformatics.
- Whole-genome sequencing of iPS cells before transplantation is a critical safety measure.
- Further development and application of these technologies align with the Human Genome Project's goal of improving human health through novel therapies.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.